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The uptake of apoptotic cells by phagocytes is defined as efferocytosis. In this issue of Cell Host & Microbe,
Martin et al. (2012) and Yang et al. (2012) report that macrophage- and neutrophil-mediated efferocytosis of
apoptotic cells containing mycobacteria is an innate antibacterial effector mechanism.The interaction of Mycobacterium tuber-
culosis (Mtb) with its host cell is complex,
and the mechanisms underlying these
interactions are only beginning to be
elaborated. The topic of Mtb-induced
cell death, for example, has been very
confusing, since depending on the study
Mtb could either induce or inhibit host
cell death (Briken andMiller, 2008). During
the past 5 years, tremendous progress
has been made leading to a conceptual
framework by which Mtb inhibits host-
cell apoptosis early during its intracellular
life cycle but induces host-cell necrosis
later (Behar et al., 2010). Consistently,
Mtb mutants deficient in inhibiting host-
cell apoptosis are less virulent (Ernst,
2012). Furthermore, the increased resis-
tance to Mtb infections of different mouse
strains is directly correlated with the
capacity of their macrophages to induce
apoptosis upon Mtb infection (Briken
and Miller, 2008).
The documented importance for Mtb
to inhibit host-cell apoptosis notwith-
standing, it is still unclear how increased
host-cell apoptosis leads to an increase
in host resistance to mycobacterial infec-
tions. The study by Martin et al. (2012)
addresses this question and establishesan elegant experiment system that
allows the ex vivo and in vivo analysis
of efferocytosis involving Mtb-infected
macrophages. CD45.2-expressing mac-
rophages are fluorescently labeled and
then infected ex vivo with Mtb expressing
a fluorescent (mCherry) protein. Next,
the infected macrophages are transferred
intratracheally into congenic (CD45.1+)
mice. After various times total lung
macrophage are harvested, and the
infected macrophages (mCherry+) can
then be sorted into three groups: (1)
primary infectedmacrophages (CD45.2+),
(2) secondary infection of recipient
macrophage (CD45.1+) and (3) efferocy-
tosis of Mtb-infected, apoptotic primary
macrophage (CD45.1+ and CD45.2+)
by uninfected recipient macrophage.
Martin et al. (2012) used this system to
demonstrate that in vivo efferocytosis is
a mechanism for uptake of Mtb by unin-
fected macrophages in the mouse lung.
Furthermore, in vivo inhibition of efferocy-
tosis via injecting neutralizing antibodies
to a receptor involved in efferocytosis
leads to increased growth of Mtb. This
clearly demonstrates the importance of
efferocytosis for the innate immune
response during Mtb infection. It will bevery interesting to see if this experimental
system could be used to investigate the
role of efferocytosis on the generation of
adaptive immunity to Mtb, which would
have important implication for vaccine
design. Another compelling question that
could be addressed is whether other
phagocytes besides macrophages are
involved in efferocytosis in the lung of
Mtb-infected mice (the report by Yang
et al. (2012) points toward neutrophils)
and if the outcome (killing of Mtb) is
the same.
Furthermore, Martin et al. (2012) inves-
tigated the molecular mechanism of effer-
ocytosis-mediated killing of Mtb. They
compared the nature of the Mtb phago-
some in primary infected macrophages
to the efferocytic phagosome and
show that after efferocytosis the Mtb-
containing phagosomes mature. These
efferocytic phagosomes now accumulate
the lysosomal marker Lamp1, recruit the
vATPase, and acidify. This is in strong
contrast to the primary phagosome in
which Mtb resides, and where phago-
some maturation is inhibited (Figure 1).
Using a novel LIVE/DEAD Mtb reporter
strain, Martin et al. (2012) also demon-
strate that most of the bacteria containedptember 13, 2012 ª2012 Elsevier Inc. 261
Figure 1. Efferocytosis Is an Innate Host Defense Mechanism
The genotype of host cell and mycobacterium both determine if infection induces either necrotic or
apoptotic cell death. For example, virulent Mtb strains are able to increase lipoxin A4 (LXA4) and decrease
prostaglandin E2 (PGE2) levels, whereas the inverse is true for attenuated strains of Mtb. Apoptotic macro-
phages can be ingested by uninfected macrophages or neutrophils in a process defined as efferocytosis.
The Mtb phagosome generated during efferocytosis is enriched in lysosomal markers, recruits the vacular
ATPase, and becomes acidic. This process is defined as phagosome maturation and leads to killing of
bacteria combined with the increase in reactive oxygen species generated by the host-cell NOX2
complex. In contrast, necrosis of host macrophages releases bacteria, which can then infect other phago-
cytes, inhibit phagosome maturation, replicate, and induce host-cell necrosis to repeat the cycle.
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authors propose that the loss of Mtb’s
capacity to inhibit phagosome maturation
in efferocytic phagosomes may be due to
the extra lipid bilayer that separates Mtb
from its host-cell protein targets needed
for this manipulation. Another aspect
that has not yet been addressed is
whether there is a difference in host-cell
signaling after efferocytosis of a dead
uninfected macrophage versus a dead
Mtb-infected macrophage, similar to the
differences reported in dendritic cells
after uptake of apoptotic bodies gener-
ated from uninfected or mycobacteria-in-
fected cells (Winau et al., 2006).
Zebrafish infected with the natural the
fish pathogen M. marinum (Mm) is
a powerful model system to study innate
immune responses early during myco-
bacterial infection (Tobin and Ramak-
rishnan, 2008). Initially, Yang et al. (2012)262 Cell Host & Microbe 12, September 13, 2discovered that the gfp gene driven by
the lysozyme C promoter in transgenic
zebrafish is only expressed in neutrophils
starting at 48 hr after fertilization, whereas
earlier GFP-positive cells also include
macrophages. This discovery opened
the door to use the the zebrafish model
to specifically analyze the temporal and
spatial response of neutrophils to myco-
bacterial infections, which is currently
not well understood. Using this system
the first surprising finding by Yang et al.
(2012) was that neutrophils, despite their
presence, did not appear to phagocytose
extracellular mycobacteria at the site of
infection, which was in stark contrast to
neutrophils at the site of infection with
Pseudomonas aeruginosa. Nevertheless,
2–4 days postinfection neutrophils
with intracellular mycobacteria could be
detected, and they were always found at
the anatomical sites of granuloma forma-012 ª2012 Elsevier Inc.tion in the fish. In a demonstration of the
advantages of the zebrafish model Yang
et al. (2012) used live in vivo imaging to
visualize the uptake of infected macro-
phages by uninfected neutrophils. The
morphology suggested that these macro-
phages were undergoing apoptosis. The
use of apoptosis inhibitors demonstrated
that the recruitment of neutrophils to
granulomas itself is dependent upon
apoptosis of cells within the granuloma.
Subsequently, the authors used a dif-
ferent transgenic zebrafish line (WHIM),
which is deficient in neutrophil trafficking,
to investigate the importance of neutro-
phils in mycobacterial infections. In these
transgenic fish neutrophils are absent
from the sites of infection and granu-
lomas, which led to an increased number
of mycobacteria and granuloma relative
to wild-type fish. Consistently, Yang
et al. (2012) could demonstrate that
neutrophils are able to kill mycobacteria
contained within the ingested macro-
phages. This killing was dependent on
the generation of reactive oxygen species
by the phagocyte oxidase NOX2 complex
(Figure 1). In summary, these data clearly
demonstrate a protective role for neutro-
phils during the innate phase of the
immune response to mycobacteria. The
authors argue that this role might have
previously been missed because many
earlier studies used only ex vivo infection
models, which were not designed to
detect neutrophil killing of mycobacteria
via efferocytosis. Other studies demon-
strated that lung neutrophils facilitate
activation of CD4 T cells during Mtb
infections, and Mtb-mediated apoptosis
inhibition of infected lung neutrophils is
important to avoid accelerated CD4
T cell responses (Blomgran et al., 2012;
Ernst, 2012). Altogether these recent
reports and the current study by Yang
et al. (2012) underline the importance of
increasing our understanding of the role
of neutrophils during Mtb pathogenesis.
Furthermore, Yang et al. (2012) provide
a second line of evidence in addition to
the paper by Martin et al. (2012) for the
importance of efferocytosis during the
innate immune response against myco-
bacteria in vivo.
Despite setting out to address two
apparently very different questions in my-
cobacterial pathogenesis, both research
groups have come to one common
central finding, which is that efferocytosis
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bacteria. This expands the well-docu-
mented role of efferocytosis in the pre-
vention of inflammatory responses to a
function in the innate immune defense.
In addition, it is likely that efferocytosis
also plays a role in the immune defense
against other intracellular pathogens
(Chlamydia, Legionella) that are known
to inhibit host-cell apoptosis during
part of their life cycle (Behar et al., 2010;
Briken and Miller, 2008). Consequently,
one could now hypothesize that en-
hancing host efferocytosis may not only
help to prevent excessive tissue injury
during the immune response but also
help in clearance of the pathogen, since
Martin et al. (2012) showed that inhibi-
tion of efferocytosis in vivo leads to an
increase in bacterial growth. For example,
the high-mobility group box 1 (HMGB1)
protein negatively regulates efferocy-
tosis (Banerjee et al., 2011). Hence,stimulating efferocytosis may be one of
the mechanisms by which the treatment
of mice with neutralizing HMGB1 anti-
bodies enhanced the clearance of
P. aeruginosa in a mouse cystic fibrosis
model (Entezari et al., 2012). One
could thus envision a novel treatment
approach for tuberculosis, which would
ideally take advantage of the putative
synergy of new antimycobacterial drugs
inhibiting the capacity of Mtb to sup-
press host-cell apoptosis with host immu-
nomodulatory therapeutics stimulating
efferocytosis.REFERENCES
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To ensure spread from one cell to another, exocytosed vaccinia virions recruit cellular actin polymerization
machinery to blast off from the cell surface on actin tails. Humphries et al. (2012) now show that the virus
exploits clathrin to organize viral factors into a launch pad that facilitates efficient actin tail formation.Viruses are orders of magnitude smaller
than their host cells, yet they not only
take control of the entire cell, but assure
that viral and cellular proteins cluster
in distinct areas of the plasma mem-
brane to facilitate production and/or
release of progeny viruses. To achieve
this, it is more economic for a virus
with limited coding capacity to subvert
already existing cellular solutions. In
this issue of Cell Host & Microbe,
Humphries et al. describe how vaccinia
virus (VACV) exploits clathrin in a non-
conventional manner to organize viral
and cellular proteins at the plasma mem-
brane to promote virus spread (Humph-
ries et al., 2012).Poxviruses are complex DNA viruses,
which include variola virus, the causative
agent of smallpox, and VACV, which
was used as a live vaccine to eradicate
the former. During replication, two infec-
tious forms of poxviruses are produced:
those surrounded by a single lipid bilayer,
the so-called intracellular mature virions
(IMVs), and those surrounded by two
membranes. The latter can either disso-
ciate from the producer cell as extracel-
lular enveloped virions (EEVs) or remain
attached to the plasma membrane, in
which case they are referred to as cell-
associated enveloped virions (CEVs).
The formation of CEVs is a complex
cytoplasmic dance whereby single-envel-oped IMVs transiently acquire two addi-
tional membranes from a virus-modified
organelle. The newly formed intracellular
enveloped virions (IEVs) are surrounded
by three membranes. These virions are
transported along microtubules and actin
filaments to the cell surface, where the
outermost viral membrane fuses with the
plasma membrane. The viral transmem-
brane protein A36 is exclusively located
in this outermost membrane and thus
remains below exocytosed CEVs after
fusion. To enhance virus spread, CEVs
use A36 to direct the formation of actin
tails propelling them toward neighboring
cells (Cudmore et al., 1995). In a series
of elegant papers, the Way lab hasptember 13, 2012 ª2012 Elsevier Inc. 263
